Startup profile · funding coverage
Pilgrim funding, valuation and investors
Biosecurity startup developing airborne pathogen detection systems; raised $25 million of seed funding at a reported $150 million valuation.
Keep track of Pilgrim
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$25M · September 24, 2026
Latest known valuation
$150M
Seed · September 24, 2026
Total disclosed equity funding
$25M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Redwood City, California, USA
Investors in latest funding
Other: Peter Thiel , Fred Ehrsam , Dylan Field , Logan Graham , Sholto Douglas
Overview
Pilgrim is a Redwood City biosecurity startup developing systems to detect airborne biological threats. The Wall Street Journal reported that Pilgrim raised $25 million in seed funding at a $150 million valuation from investors including Peter Thiel, Fred Ehrsam, Dylan Field and Anthropic leaders Logan Graham and Sholto Douglas.
Why Pilgrim is interesting
The round connects biosecurity, AI-risk concerns and prominent technology founders, with a disclosed valuation and unusually strong strategic relevance.
Key facts
- Sep 2026: $25M seed at a reported $150M valuation
- Product focuses on airborne pathogen and biological-threat detection
Funding history (newest first)
Seed
2026-09-24 $25M Valuation: $150M- Peter Thiel (participant)
- Fred Ehrsam (participant)
- Dylan Field (participant)
- Logan Graham (participant)
- Sholto Douglas (participant)
Market / IPO context
Note: WSJ reported a $150M valuation in connection with the $25M seed round.
Editorial / static context — not a live quote.
FAQs about Pilgrim
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.